Global Biomarker Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Biomarker Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention."
Biomarker report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biomarker market is projected to reach US$ 68010 million in 2033, increasing from US$ 28570 million in 2022, with the CAGR of 12.7% during the period of 2023 to 2033. Demand from Diagnostics Development and Drug Discovery and Development are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biomarker industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biomarker key companies include F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG, General Electric, Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH and QIAGEN, etc. F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG are top 3 players and held % share in total in 2022.
Biomarker can be divided into Consumables and Service, etc. Consumables is the mainstream product in the market, accounting for % share globally in 2022.
Biomarker is widely used in various fields, such as Diagnostics Development, Drug Discovery and Development, Disease-Risk and Other, etc. Diagnostics Development provides greatest supports to the Biomarker industry development. In 2022, global % share of Biomarker went into Diagnostics Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biomarker market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
F. Hoffmann-La Roche Ltd.
Abbott
Epigenomics AG
General Electric
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthcare GmbH
QIAGEN
Segment by Type
Consumables
Service
Diagnostics Development
Drug Discovery and Development
Disease-Risk
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biomarker market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biomarker introduction, etc. Biomarker Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Biomarker market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Biomarker report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biomarker market is projected to reach US$ 68010 million in 2033, increasing from US$ 28570 million in 2022, with the CAGR of 12.7% during the period of 2023 to 2033. Demand from Diagnostics Development and Drug Discovery and Development are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biomarker industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biomarker key companies include F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG, General Electric, Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH and QIAGEN, etc. F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG are top 3 players and held % share in total in 2022.
Biomarker can be divided into Consumables and Service, etc. Consumables is the mainstream product in the market, accounting for % share globally in 2022.
Biomarker is widely used in various fields, such as Diagnostics Development, Drug Discovery and Development, Disease-Risk and Other, etc. Diagnostics Development provides greatest supports to the Biomarker industry development. In 2022, global % share of Biomarker went into Diagnostics Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biomarker market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
F. Hoffmann-La Roche Ltd.
Abbott
Epigenomics AG
General Electric
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthcare GmbH
QIAGEN
Segment by Type
Consumables
Service
Segment by Application
Diagnostics Development
Drug Discovery and Development
Disease-Risk
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biomarker market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biomarker introduction, etc. Biomarker Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Biomarker market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices